News
9,433 News Articles
Oct
07
2022
The Biden Administration To Pardon Thousands Of Marijuana Convictions | News - BET
Cannabis will not be decriminalized, but the White House will examine if weed should be considered as dangerous as LSD or heroin.
LSD
Cannabis
Oct
07
2022
Decaf Acid: New LSD Derivatives May Offer Mental Health Benefits Without the Trip
A study on newly-derived LSD derivatives claims these compounds may be able to treat depression without the additional 12-hour long magic carpet ...
LSD
Oct
07
2022
LSD for Anxiety: A Deep Dive Into a New Clinical Trial | Technology Networks
A Phase II clinical trial investigating the efficacy of the psychedelic compound lysergic acid diethylamide (LSD)-assisted psychotherapy for the ...
Oct
07
2022
Psychedelic Medicine May Be an Effective Treatment for Alcoholism - Pharmacy Times
Pharmacy Times interviewed Adi Zoloff-Shani, PhD, founder of Clearmind Medicine, on the benefits of psychedelics in overcoming certain mental ...
Oct
07
2022
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials - Benzinga
Biopharma R&D company Mindset Pharma Inc. MSSTF. has performed preclinical screening studies and selected MSP-2020 as the lead psychedelic drug ...
Psychedelics
Oct
07
2022
New York Update: Will Psychedelics Gain Legal Status in 2023? - Press Release
Member of the Democratic Assembly Linda Rosenthals The Psychedelics Act of 2021 was intentional delist Psilocybin and Psilocin as List I ...
Psilocybin
Psychedelics
Oct
07
2022
Maegical With Maegan and David Staab - Cannabis Radio
Maegical With Maegan and David Staab today on Psychedelic Radio with Christina Thomas, president and founder of MY Self Wellness, and Charles ...
Cannabis
Oct
07
2022
Alberta Becomes First Canadian Province to Approve Psychedelics for Therapy
In a briefing on Wednesday, Alberta health officials said they are laying out a regulatory groundwork for anticipated psychedelic therapy.
Psychedelics
Oct
07
2022
New Study Looks At Psychedelics And Near-Death Experiences: How They Influence ... - Benzinga
Similarly, those who embark on psychedelic journeys often allude to mystical experiences, the death of ego, a sense of oneness with creation, and how ...
Psychedelics
Oct
07
2022
Psychedelic drugs and new mental health treatments. Published Oct. 7 2022. Opinion.
Researchers are investigating a new generation of drugs for treating mental illness derived from psychedelic substances. A molecule known as ...
Oct
07
2022
Opinion | Biden's marijuana pardons might help the decriminalization effort - The Washington Post
... Biden ordered a review of whether marijuana should continue to be classified as a Schedule I substance, the same category as heroin and LSD.
Oct
07
2022
The Fear of Death and the Rise of Psychedelics | Psychology Today
Psychedelic drugs have already shown success with the terminally ill, especially with those who experience a form of existential distress and ...
Psychedelics
Oct
07
2022
Psychedelic Drugs Market will Expand at a CAGR of ~8% by 2031 - EIN News
Psychedelic drugs are potent psychoactive substances, used to modify the perception and mood of a depressed person by affecting the cognitive ...
Oct
07
2022
Virtually Malpractice - Psychiatric Times
Both ketamine and esketamine are Schedule 3 drugs, and ketamine has a ... sublingual ketamine telehealth for moderate to severe anxiety and ...
Oct
07
2022
Revitalist Company Update Regarding Financial and Share Settlements - Yahoo Finance
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is one of the largest publicly listed, ketamine focused clinic ...
Oct
07
2022
Alberta Allows Community Facilities to Provide Ketamine Injections - StreetInsider
In Alberta, Canada, patients with serious mental health conditions such as depression will now be able to access ketamine treatments in… Read More>>.
Ketamine
Oct
07
2022
Ketamine use demonstrates promise for treatment-resistant depression | 2 Minute Medicine
1. Ketamine use in patients with treatment-resistant depression resulted in more belief-updating that was optimistically biased.
Ketamine
Oct
07
2022
Core One Labs Nearing GMP Production as Canada's Province of Alberta Announces ...
The goal of the Company is to create pharmaceutical grade psychedelic products ... itself as a trusted manufacturer of GMP compliant psychedelics.
Oct
07
2022
CND Life Sciences receives NIH grant to study REM sleep behaviour disorder
Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation ... Choose Ketamine now offering at home treatments in several states ...
Ketamine
Oct
07
2022
Don't Have an Unsafe Trip - Crozet Gazette
Psychedelics (“hallucinogens”) are substances that produce unfamiliar changes in thinking, perception and mood. Effects can include hallucinations ...
MDMA
Psychedelics
Oct
07
2022
Jack Parow: Magic mushrooms helped during hard lockdown - The Citizen
Afrikaans rapper Jack Parow was depressed after the Covid lockdown until he went for psilocybin mushroom treatment that inspired a new album.
Oct
07
2022
Ballot measure would make Colorado second state in the country to decriminalize ... - CBS News
Denver Mayor Michael Hancock says he is opposed to a ballot measure that would decriminalize psychedelic mushrooms statewide.
Oct
07
2022
Alberta Becomes First Province In Canada To Regulate Psychedelics-Assisted Therapy
Alberta will be the first to province offer supervised psychedelics-assisted therapy of substances such as psilocybin, MDMA, LSD, mescaline.
Oct
07
2022
Emerald Announces the Launch of remind, A New Business Resource for the Psychedelics ...
Once stigmatized substances, psychedelics are now proving to be powerful tools in the fight against depression, addiction, PTSD, anxiety, ...
Psychedelics
Oct
07
2022
Three years after clinical trial, ketamine provides hope for severely depressed - yoursun.com
LOS ANGELES — Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost.
Oct
06
2022
Ketamine for Parkinson's Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a pharmaceutical company focused on developing novel uses and delivery forms of ketamine.
Oct
06
2022
Alberta sets standards for psychedelic drug-assisted therapy | Globalnews.ca
Psychedelic drugs include psilocybin, psilocin, MDMA, LSD, mescaline (peyote), DMT, 5 methoxy DMT and ketamine.
DMT
Oct
06
2022
Nevada lawmakers and researchers advocate for psychedelics in medicine
For decades, mainstream culture has associated psychedelics with impairing the mind rather than improving it. But advocates, researchers and ...
Oct
06
2022
Scientists Create Trip-Free LSD-Based Drugs to Potentially Treat Anxiety and Depression
While psychedelics like magic mushrooms or LSD can act as powerful antidepressants, they can also cause vivid hallucinations that limit their use.
LSD
Oct
06
2022
Mice Get Rid of Depression Due to LSD Variant, New Experiment Shows
A new experiment having mice as the protagonists shows that an LSD variant can treat their depression, even without making the animals go through ...
LSD
Oct
06
2022
Psilocybin: a revolution in psychedelic medicines in the US? - The BMJ
Decades later, psychedelics—with psilocybin, the active ingredient in magic mushrooms, in the lead—are making a medical comeback in the US.
Oct
06
2022
Transforming Psychedelics into Approved Medicines - Genetic Engineering and Biotechnology News
Today, however, psychedelic drugs are making a comeback. New research indicates that psychotropic substances can improve mental well-being by ...
Psychedelics
Oct
06
2022
A grad student finds a 'typo' in a psychedelic study's script that leads to a retraction
Titled “A mechanistic model of the neural entropy increase elicited by psychedelic drugs,” the paper purported to help illuminate what happens in ...
Oct
06
2022
Can Non-Oregon Residents Get Psilocybin Licenses? - Lexology
Our psychedelics team routinely fields questions from non-Oregon residents looking for Oregon psilocybin licenses. However, one of Measure 109's ...
Psilocybin
Oct
06
2022
Wellbeing Subsidiary KGK Science Announces Psilocybin Microdose Capsule ... - Business Wire
The psilocybin 1.5mg capsules are available for potential therapeutic use in non-ASD clinical trials, including but not limited to diabetes, ...
Psilocybin
Oct
06
2022
Wellbeing Subsidiary KGK Science Announces Psilocybin Microdose Capsule ... - Chronicle-Tribune
(“KGK”), today announced that the Company has completed the CMC package to be used in support of a phase 2A microdose psilocybin fragile X syndrome ...
Psilocybin